{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0859372/OMIM:620236","label":"Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies","mondoId":"MONDO:0859372","onsetQualifier":null,"recordKeys":["07b260c42b24cc5b38f723555cd159dfa6bb37c75aade509394478aff66dc46c","08a15e4776989e07a7fab54365cdfcff52c7e79fcf32b0101258d12b0e74b250","0c88df07afde72dca3b79dd55ca1f8ea480caccbd705f39f1b5fcb4693c76a90","154b174d2b7938b00958c5a50d15392593a579f98187a4cf9d5747874f9a02cd","1c2a281e9e0ef05b1d982c409555485284beb5b820e5dde06fe937ee2991d753","2d8865bb4ad9c79971d496ded9a3181444ba60913a7c6ad6fa722c3e04e61ecf","616daf4ad50b3eb5e4f21202e99d059b0334949d2f03673171aa5794f0eca41f","7d92a4da5aa96f2cc01399c9a82b5efe054474d9d9b297e349ee29c72e098226","9ab1d2ca965f64434db30c53c6fe4990745ade2d3736e9bc72b952b1cfb3e639","bedec143e28c6a9cd6e81f8b3193d298acb72a40761813a685fdc04bde609aa8","f4ad79cd63152b3cc34cc2866f00017ad35548712e81fa8100d28aa1778a46e9"],"recordQualifiers":{},"scopeLabel":"OMIM:620236","sourceIds":["OMIM:620236"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0859372/OMIM:620236"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":11,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":11,"sourceGroups":{"omim":0,"orphanet":0,"published":11}},"features":[{"hpoId":"HP:0001670","label":"Asymmetric septal hypertrophy","primary":false},{"hpoId":"HP:0031319","label":"Cardiomyocyte hypertrophy","primary":false},{"hpoId":"HP:0002094","label":"Dyspnea","primary":false},{"hpoId":"HP:0034532","label":"Increased myocardial glycogen content","primary":false},{"hpoId":"HP:0032092","label":"Left ventricular outflow tract obstruction","primary":false},{"hpoId":"HP:0001653","label":"Mitral regurgitation","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0001962","label":"Palpitations","primary":false},{"hpoId":"HP:0034386","label":"Reduced left ventricular endsystolic diameter","primary":false},{"hpoId":"HP:0001645","label":"Sudden cardiac death","primary":false},{"hpoId":"HP:0031656","label":"Systolic anterior motion of the mitral valve","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0859372","records":[{"frequencyKind":"count","key":"07b260c42b24cc5b38f723555cd159dfa6bb37c75aade509394478aff66dc46c","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:620236","disease_name":"Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies","evidence":"PCS","frequency_raw":"3/8","hpo_id":"HP:0001653","is_excluded":false,"label":"Mitral regurgitation","onset_id":null,"reference":"PMID:30715372","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"08a15e4776989e07a7fab54365cdfcff52c7e79fcf32b0101258d12b0e74b250","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:620236","disease_name":"Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies","evidence":"PCS","frequency_raw":"0/8","hpo_id":"HP:0001324","is_excluded":true,"label":"Muscle weakness","onset_id":null,"reference":"PMID:30715372","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"0c88df07afde72dca3b79dd55ca1f8ea480caccbd705f39f1b5fcb4693c76a90","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:620236","disease_name":"Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies","evidence":"PCS","frequency_raw":"4/8","hpo_id":"HP:0031656","is_excluded":false,"label":"Systolic anterior motion of the mitral valve","onset_id":null,"reference":"PMID:30715372","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"154b174d2b7938b00958c5a50d15392593a579f98187a4cf9d5747874f9a02cd","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:620236","disease_name":"Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0034532","is_excluded":false,"label":"Increased myocardial glycogen content","onset_id":null,"reference":"PMID:30715372","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1c2a281e9e0ef05b1d982c409555485284beb5b820e5dde06fe937ee2991d753","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:620236","disease_name":"Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies","evidence":"PCS","frequency_raw":"5/7","hpo_id":"HP:0001962","is_excluded":false,"label":"Palpitations","onset_id":null,"reference":"PMID:30715372","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2d8865bb4ad9c79971d496ded9a3181444ba60913a7c6ad6fa722c3e04e61ecf","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:620236","disease_name":"Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies","evidence":"PCS","frequency_raw":"5/7","hpo_id":"HP:0002094","is_excluded":false,"label":"Dyspnea","onset_id":null,"reference":"PMID:30715372","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"616daf4ad50b3eb5e4f21202e99d059b0334949d2f03673171aa5794f0eca41f","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:620236","disease_name":"Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0031319","is_excluded":false,"label":"Cardiomyocyte hypertrophy","onset_id":null,"reference":"PMID:30715372","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7d92a4da5aa96f2cc01399c9a82b5efe054474d9d9b297e349ee29c72e098226","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:620236","disease_name":"Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies","evidence":"PCS","frequency_raw":"5/7","hpo_id":"HP:0034386","is_excluded":false,"label":"Reduced left ventricular endsystolic diameter","onset_id":null,"reference":"PMID:30715372","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9ab1d2ca965f64434db30c53c6fe4990745ade2d3736e9bc72b952b1cfb3e639","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:620236","disease_name":"Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies","evidence":"PCS","frequency_raw":"3/8","hpo_id":"HP:0001670","is_excluded":false,"label":"Asymmetric septal hypertrophy","onset_id":null,"reference":"PMID:30715372","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"bedec143e28c6a9cd6e81f8b3193d298acb72a40761813a685fdc04bde609aa8","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:620236","disease_name":"Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies","evidence":"PCS","frequency_raw":"3/11","hpo_id":"HP:0001645","is_excluded":false,"label":"Sudden cardiac death","onset_id":null,"reference":"PMID:30715372","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f4ad79cd63152b3cc34cc2866f00017ad35548712e81fa8100d28aa1778a46e9","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:620236","disease_name":"Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies","evidence":"PCS","frequency_raw":"3/8","hpo_id":"HP:0032092","is_excluded":false,"label":"Left ventricular outflow tract obstruction","onset_id":null,"reference":"PMID:30715372","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"cardiomyopathy-familial-hypertrophic-29-with-polyglucosan-bodies","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies"},"schemaVersion":1}